NM_000059.4(BRCA2):c.2963A>C (p.Asp988Ala) AND Hereditary cancer-predisposing syndrome
- Germline classification:
- Conflicting interpretations of pathogenicity (2 submissions)
- Last evaluated:
- Mar 23, 2023
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV000218795.14
Allele description [Variation Report for NM_000059.4(BRCA2):c.2963A>C (p.Asp988Ala)]
NM_000059.4(BRCA2):c.2963A>C (p.Asp988Ala)
Condition(s)
- Name:
- Hereditary cancer-predisposing syndrome
- Synonyms:
- Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]
- Identifiers:
- MONDO: MONDO:0015356; MeSH: D009386; MedGen: C0027672
-
Ergolines
ErgolinesA series of structurally-related alkaloids that contain the ergoline backbone structure.<br/>Year introduced: 1969MeSH
-
Galantamine
GalantamineA benzazepine derived from norbelladine. It is found in GALANTHUS and other AMARYLLIDACEAE. It is a cholinesterase inhibitor that has been used to reverse the muscular effects...<br/>Year introduced: 2004(1999)MeSH
-
Betacyanins
BetacyaninsConjugates of betalamic acid with cyclo-dopa, both of which derive from TYROSINE. They appear similar to INDOLES but are biosynthesized by a different path and contain N+. Mem...<br/>Year introduced: 2006MeSH
-
Dihydro-beta-Erythroidine
Dihydro-beta-ErythroidineDihydro analog of beta-erythroidine, which is isolated from the seeds and other plant parts of Erythrina sp. Leguminosae. It is an alkaloid with curarimimetic properties....<br/>Year introduced: 1991(1975)MeSH
Your browsing activity is empty.
Activity recording is turned off.
See more...Assertion and evidence details
Last Updated: Nov 10, 2024